Liquidity Risk in 2025: A Strategic Priority, Not a Side Concern

Published on May 13, 2025

In 2025, liquidity is not a background variable — it's a front-line risk factor, one that’s being tested repeatedly as global markets navigate a web of geopolitical uncertainty and macroeconomic signals.

Continue reading on website
Other news

How to Cut US Drug Prices Without Hurting Innovation

May 13, 2025
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the US; in Germany, it’s $328. The US price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000.

Federal Reserve Board announces termination of enforcement action with Perry County Bancorp Inc. and Du Quoin State Bank

May 13, 2025
Federal Reserve Board announces termination of enforcement action with Perry County Bancorp Inc. and Du Quoin State Bank